State Of Wisconsin Investment Board Fulcrum Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.26 - $3.8 $50,239 - $84,474	22,230 Added 23.46%	117,000 $386,000
Q1 2023 May 15, 2023	SELL	$2.83 - $13.99 $88,199 - $436,012	-31,166 Reduced 24.75%	94,770 $270,000
Q4 2022 Feb 14, 2023	BUY	$5.01 - $8.35 $311,867 - $519,779	62,249 Added 97.74%	125,936 $916,000
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $174,182 - $322,167	35,403 Added 125.17%	63,687 $515,000
Q2 2022 Aug 15, 2022	SELL	$4.2 - $24.0 $27,787 - $158,784	-6,616 Reduced 18.96%	28,284 $139,000
Q1 2022 May 13, 2022	SELL	$9.96 - $23.65 $223,104 - $529,760	-22,400 Reduced 39.09%	34,900 $825,000
Q4 2021 Feb 11, 2022	BUY	$14.0 - $28.44 $611,800 - $1.24 Million	43,700 Added 321.32%	57,300 $1.01 Million
Q3 2021 Nov 12, 2021	BUY	$7.28 - $30.97 $99,008 - $421,192	13,600 New	13,600 $384,000
Q2 2021 Aug 12, 2021	SELL	$8.09 - $12.0 $160,991 - $238,800	-19,900 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$7.84 - $13.4 $3,136 - $5,360	400 Added 2.05%	19,900 $233,000
Q1 2020 May 06, 2020	BUY	$9.49 - $21.26 $185,055 - $414,570	19,500 New	19,500 $233,000

150

52.2M

6.91M

1.9M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.